Abstract
Dimensional personality characteristics (e.g. impulsivity) and related behaviors and psychiatric disorders are linked to abnormalities of central nervous system (CNS) serotonergic functioning. Although neuroendocrine [e.g. plasma prolactin (PRL)] responses to the serotonin agonist, fenfluramine, have been used widely to index CNS serotonergic responsivity, safety concerns constrain continued use of fenfluramine. Citalopram, which inhibits serotonin reuptake, may serve as an alternative pre-synaptic neuropharmacologic challenge agent, due to its high selectivity and absence of intrinsic activity at serotonin or other receptor families. Twenty-two healthy adults who had been administered a fenfluramine challenge before May 1996 completed a 5-h oral citalopram challenge 3–6 years later. PRL responsivity to citalopram correlated significantly with PRL response to fenfluramine for baseline-corrected maximal and area-under-the-curve (AUC) indices (r‘s≥0.49, P‘s≤0.02). The magnitude of the correlations is notable given the length of time between challenges. The results support the use of citalopram as an alternate neuroendocrine challenge to index CNS serotonergic responsivity.
Similar content being viewed by others
References
Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ (2001) Low-dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology 155:323-326
Bhagwagar Z, Whale R, Cowen PJ (2002) State and trait abnormalities in serotonin function in major depression. Br J Psychiatry 180:24-28
Borroni E, Ceci A, Garrattini S, Mennini T (1983) Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms. J Neurochem 40:891–893
Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL (1989) Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46:587–599
Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Sclaff HV (1997) Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337:581-588
Evans J, Platt H, Lightman S, Nutt D (2000) Impulsiveness and the prolactin response to d-fenfluramine. Psychopharmacology 149:147–152
Flory JD, Mann JJ, Muldoon M, Manuck SB (1998) Recovery from major depression is not associated with normalization of serotonergic function. Biol Psychiatry 43:320–326
Flory JD, Manuck SB, Muldoon MF (2002) Retest reliability of prolactin response to dl-fenfluramine challenge in adults. Neuropsychopharmacology 26:269-272
Golden RN, Gilmore JH, Ekstrom RD, Knight B, Ruegg RG, Miller HL, Carson SW (1996) The effects of age, gender and season on serotonergic function in healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry 20:1315–1323
Hennig J, Netter P (2002) Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests. Intl J Neuropsychopharmacol 5:67-71
Hiemke C, Härtter H (2000) Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 85:11-28
Joubert AF, Sanchez C, Larson F (2000) Citalopram. Hum Psychopharmacol 15:439-451
Kapitany T, Schindl M, Schindler SD, Hebelmann B, Fureder T, Barnas C, Sieghart W, Kasper S (1999) The citalopram challenge test in patient with major depression and in healthy controls. Psychiatry Res 88:75-88
Malone KM, Corbitt EM, Li S, Mann JJ (1996) Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 168:324–329
Manuck SB, Flory JD, McCaffery JM, Matthews KA, Mann JJ, Muldoon MF (1998) Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology 19:287-299
McBride PA, Tierney H, DeMeo M, Chen J-S, Mann JJ (1990) Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 27:1143–1155
Murphy DL, Mellow AM, Sunderland T, Aulakh CS, Lawlor BL, Zohar J (1990) Strategies for the study of serotonin in humans. In: Coccaro EF, Murphy DL (eds) Serotonin in major psychiatric disorders. American Psychiatric Press, Washington D.C., pp 2-25
Netter P, Toll C, Lujic C, Reuter M, Hennig J (2002) Addictive and nonaddictive smoking as related to responsivity to neurotransmitter systems. Behav Pharmacol 13:441-449
O’Keane V, McLoughlin D, Dinan TG (1992) d-Fenfluramine-induced prolactin and cortisol release in major depression: response to treatment. J Affect Disord 26:143–150
Seifritz E, Baumann P, Muller MJ, Annen O, Amey M, Hemmeter U, Hatzinger M, Chardon F, Holsboer-Trachsler E (1996) Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. Neuropsychopharmacology 14:253-263
Soloff PH, Kelly TM, Strotmeyer SJ, Malone KM, Mann JJ (2003) Impulsivity, gender and response to fenfluramine challenge in borderline personality disorder. Psychiatry Res 119:11–24
Yatham LN, Steiner M (1993) Neuroendocrine probes of serotonergic function: a critical review. Life Sci 53:447-463
Acknowledgement
This research was supported by NIH grants HL46328 (M.F.M.), HL 40962 (S.B.M.) and NIH/NCRR/GCRC grant #5 MO1 RR0056 (G.C.R.C.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Flory, J.D., Manuck, S.B., Perel, J.M. et al. A comparison of d,l-fenfluramine and citalopram challenges in healthy adults. Psychopharmacology 174, 376–380 (2004). https://doi.org/10.1007/s00213-003-1763-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-003-1763-9